The structure of human interferon lambda and what it has taught us

Journal of Interferon and Cytokine Research

Volumn 30, Issue 8, 2010, Pages 565-571

  Gad, Hans Henrik ^a,b   Hamming, Ole Jensen ^a   Hartmann, Rune ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CYTOKINE; INTERFERON; INTERFERON LAMBDA; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 22; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; DISULFIDE BOND; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

CRYSTALLIZATION; HUMANS; INTERLEUKIN-10; INTERLEUKINS; MOLECULAR CONFORMATION; PROTEIN ISOFORMS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77955873326     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0062     Document Type: Review

References (42)

1. Bazan JF. 1990. Shared architecture of hormone binding domains in type I and II interferon receptors. Cell 61:753-754.
2. Bleicher L, de Moura PR, Watanabe L, Colau D, Dumoutier L, Renauld JC, Polikarpov I. 2008. Crystal structure of the IL-22/ IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett 582:2985-2992.
3. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A, and others. 2001. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9-19.
4. Chang C, Magracheva E, Kozlov S, Fong S, Tobin G, Kotenko S, Wlodawer A, Zdanov A. 2003. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278:3308-3313.
5. Dellgren C, Gad HH, Hamming OJ, Melchjorsen J, Hartmann R. 2009. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun 10:125-131.
6. Fountoulakis M, Juranville JF, Maris A, Ozmen L, Garotta G. 1990. One interferon gamma receptor binds one interferon gamma dimer. J Biol Chem 265:19758-19767.
7. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R. 2009. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 284:20869-20875.
8. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vazquez N, Pestka S, Donnelly RP, Kotenko SV. 2000. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1:442-450.
9. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, and others. 2009. Genetic variation in IL28B predicts hepatitis C treatmentinduced viral clearance. Nature 461:399-401.
10. Glasgow LA. 1965. Leukocytes and interferon in the host response to viral infections. I. Mouse leukocytes and leukocyteproduced interferon in vaccinia virus infection in vitro. J Exp Med 121:1001-1018.
11. Hardy MP, Owczarek CM, Jermiin LS, Ejdeback M, Hertzog PJ. 2004. Characterization of the type I interferon locus and identification of novel genes. Genomics 84:331-345.
12. Hauptmann R, Swetly P. 1985. A novel class of human type I interferons. Nucleic Acids Res 13:4739-4749.
13. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258-267.
14. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. 1995. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11:2477-2486.
15. Josephson K, Logsdon NJ, Walter MR. 2001. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 15:35-46.
16. Karpusas M, Nolte M, Benton CB, Meier W, Lipscomb WN, Goelz S. 1997. The crystal structure of human interferon beta at 2.2-A resolution. Proc Natl Acad Sci U S A 94:11813-11818.
17. Knappe A, Hor S, Wittmann S, Fickenscher H. 2000. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 74:3881-3887.
18. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77.
19. Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S. 1997. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16:5894-5903.
20. Kotenko SV, Pestka S. 2000. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19:2557-2565.
21. LaFleur DW, Nardelli B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, and others. 2001. Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem 276:39765-39771.
22. Martal JL, Chene NM, Huynh LP, L'Haridon RM, Reinaud PB, Guillomot MW, Charlier MA, Charpigny SY. 1998. IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 80:755-777.
23. Nagem RA, Colau D, Dumoutier L, Renauld JC, Ogata C, Polikarpov I. 2002. Crystal structure of recombinant human interleukin-22. Structure 10:1051-1062.
24. Novick D, Cohen B, Rubinstein M. 1994. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77:391-400.
25. Radhakrishnan R, Walter LJ, Hruza A, Reichert P, Trotta PP, Nagabhushan TL, Walter MR. 1996. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure 4:1453-1463.
26. Rosenbloom J, McArthur W, Malamud D, Jimenez S. 1983. Characterization of a lymphokine produced by human T cells which inhibits collagen synthesis. Cell Immunol 81:192-198.
27. Samudzi CT, Burton LE, Rubin JR. 1991. Crystal structure of recombinant rabbit interferon-gamma at 2.7-A resolution. J Biol Chem 266:21791-21797.
28. Senda T, Shimazu T, Matsuda S, Kawano G, Shimizu H, Nakamura KT, Mitsui Y. 1992. Three-dimensional crystal structure of recombinant murine interferon-beta. EMBO J 11:3193-3201.
29. Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, Anantha S, Dickensheets H, Dumoutier L, Renauld JC, Zdanov A, and others. 2004. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 172:2006-2010.
30. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, and others. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68.
31. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017.
32. Tanimoto T, Yamamoto S, Taniai M, Taniguchi M, Ariyasu H, Ushio C, Aga M, Mukai Y, Tsutsumi Y, Ariyasu T, and others. 2007. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2. J Interferon Cytokine Res 27:517-523.
33. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, and others. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801.
34. Vilcek J. 1960. An interferon-like substance released from tickborne encephalitis virus-infected chick embryo fibroblast cells. Nature 187:73-74.
35. Walter MR, Nagabhushan TL. 1995. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry 34:12118-12125.
36. Walter MR, Windsor WT, Nagabhushan TL, Lundell DJ, Lunn CA, Zauodny PJ, Narula SK. 1995. Crystal structure of a complex between interferon-gamma and its soluble highaffinity receptor. Nature 376:230-235.
37. Wang M, Tan Z, Zhang R, Kotenko SV, Liang P. 2002. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 277:7341-7347.
38. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. 2004. IL-22 increases the innate immunity of tissues. Immunity 21:241-254.
39. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275:31335-31339.
40. Zdanov A. 2006. Structural studies of the interleukin-19 subfamily of cytokines. Vitam Horm 74:61-76.
41. Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J, Wlodawer A. 1995. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure 3:591-601.
42. Zdanov A, Schalk-Hihi C, Wlodawer A. 1996. Crystal structure of human interleukin-10 at 1.6A resolution and a model of a complex with its soluble receptor. Protein Sci 5:1955-1962.